Why do FAR not make it clear that the CNE valuation of $10 pb is a realistic valuation for SNE post FID. This is what they could expect to achieve in a sell down alongside CNE should POO remain at this level.
My point is why hold back on the positive side.
SNE alone if sold has the potential to lift the present market value by a factor of 4x equating to a SP of approx 25c.
Let’s get it out there to the market Or am I missing something.
MC
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.26M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 168182 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 6001 | 1 |
View Market Depth
| Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
| FAR (ASX) Chart |
Day chart unavailable